1-4 of 4
Fuqun Wu
Close
Sort by
Journal Articles

Gene Mutation Profile and Risk Stratification in AML1-ETO-Positive Acute Myeloid Leukemia Based on Next-Generation Sequencing

Guopan Yu, Changxin Yin, Fuqun Wu, Ling Jiang, Zhongxin Zheng, Dan Xu, Jiaheng Zhou, Xuejie Jiang, MD, Qifa Liu, MD, Fanyi Meng
Journal: Blood
Blood (2018) 132 (Supplement 1): 5249.
https://doi.org/10.1182/blood-2018-99-113494
Published: 2018
Journal Articles

A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Guo-Pan Yu, MD, Changxin Yin, Fuqun Wu, Dan Xu, Zhongxin Zheng, Ling Jiang, PhD MD, Fang Chen, Xuejie Jiang, MD, Qifa Liu, Fanyi Meng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5088.
https://doi.org/10.1182/blood.V130.Suppl_1.5088.5088
Published: 2017
Journal Articles

Analysis of JAK2 V617F Mutation and Its Clinical Significance in Patients with Thrombocythemia and Other Myeloproliferative Neoplasms in Chinese

Yue Xu, Changxin Yin, Han He, Lingling Shu, Fuqun Wu, Fanyi Meng, Beng Chong, MBBS, PhD, Mo Yang
Journal: Blood
Blood (2011) 118 (21): 4687.
https://doi.org/10.1182/blood.V118.21.4687.4687
Published: 2011
Journal Articles

Synergic Effects of Proteasome Inhibitor PS-341 and Tyrosine Kinase Inhibitor STI571 on Chronic Myeloid Leukemia Cells and BCR-ABL Oncoprotein In Vitro and In Vivo .

Guangbiao Zhou, MD, PhD, Zheng Hu, MS, Dapeng Liu, Fuqun Wu, Jiang Zhu, PhD, Saijuan Chen, MD, PhD, Xiaoli Liu, MD, Juan Li, MS, Xiaofeng Li, Fengxiang Zhang
Journal: Blood
Blood (2006) 108 (11): 4771.
https://doi.org/10.1182/blood.V108.11.4771.4771
Published: 2006